Unger, K., Fleischmann, D. F., Ruf, V., Felsberg, J., Piehlmaier, D., Samaga, D., . . . Niyazi, M. (2020). Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status. Neurooncol Adv.
Chicago Stili AlıntıUnger, Kristian, et al. "Improved Risk Stratification in Younger IDH Wild-type Glioblastoma Patients By Combining a 4-miRNA Signature With MGMT Promoter Methylation Status." Neurooncol Adv 2020.
MLA AlıntıUnger, Kristian, et al. "Improved Risk Stratification in Younger IDH Wild-type Glioblastoma Patients By Combining a 4-miRNA Signature With MGMT Promoter Methylation Status." Neurooncol Adv 2020.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..